Kurt J. Hilzinger, Director at Outlook Therapeutics, Inc. (OTLK), bought 17,189 shares at $0.59 ($10K) on 2018-12-31, disclosed to the SEC on 2019-01-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.59 | 11,349 | $7K | 66.0% |
| 2 | $0.59 | 1,640 | $968 | 9.5% |
| 3 | $0.59 | 4,200 | $2K | 24.4% |
| Total | $0.59 avg | 17,189 | $10K | 100% |
| Filing → |
| OTLK | BUY | 2022-10-03 | $163K | — | Filing → |
| OTLK | BUY | 2022-03-03 | $47K | — | Filing → |
| OTLK | BUY | 2022-02-28 | $130K | — | Filing → |